Document is current

Article History

Received: 26 January 2024

Accepted: 18 September 2024

First Online: 5 October 2024

Declarations

:

: Dr. Horiuchi reports other from Astra-Zeneca Co., Ltd., other from Otsuka Pharmaceutical Co., Ltd., other from Ono Pharmaceutical Co., Ltd., other from Novartis Pharma K.K., other from Bayer Yakuhin, other from Mochida Pharmaceutical Co., Ltd., other from Toa Eiyo Co., Ltd., other from Nippon Boehringer Ingelheim Co., Ltd., other from Eli Lilly Japan, grants from Asahi Intecc, outside the submitted work;. Dr. Asami reports other from Takeda Pharmaceutical Co., Ltd., other from Astra-Zeneca Co., Ltd., other from Pfizer Japan Inc., other from Bristol-Myers Squibb Company, other from Otsuka Pharmaceutical Co., Ltd., other from Daiichi Sankyo Co., Ltd., other from Nippon Boehringer Ingelheim Co., Ltd., outside the submitted work;. Dr. Yahagi reports other from Ono Pharmaceutical Co., Ltd., other from Daiichi Sankyo Co., Ltd., other from Novartis Pharma K.K., other from Nippon Boehringer Ingelheim Co., Ltd., other from Bristol-Myers Squibb Company, outside the submitted work; Dr. Komiyama reports other from Otsuka Pharmaceutical Co., Ltd., other from Daiichi Sankyo Co., Ltd., other from Novartis Pharma K.K, other from Kowa Pharmaceutical Co. Ltd., outside the submitted work;. Dr. Yuzawa reports other from Daiichi Sankyo Co., Ltd., other from Kowa Pharmaceutical Co. Ltd., outside the submitted work;. Dr. Tanaka reports other from Novartis Pharma K.K., other from Otsuka Pharmaceutical Co., Ltd., other from Nippon Boehringer Ingelheim Co., Ltd., other from Ono Pharmaceutical Co., Ltd., outside the submitted work;. Dr. Aoki reports other from Novartis Pharma K.K., other from Ono Pharmaceutical Co., Ltd., other from Otsuka Pharmaceutical Co., Ltd., other from Takeda Pharmaceutical Co., Ltd., other from Novartis Pharma K.K, other from Kowa Pharmaceutical Co. Ltd., other from Daiichi Sankyo Co., Ltd., other from Sanofi K.K., other from Amgen Ink., other from Toa Eiyo Co., Ltd., outside the submitted work;. Dr. Tanabe reports other from Astra-Zeneca Co., Ltd., other from Otsuka Pharmaceutical Co., Ltd, other from Ono Pharmaceutical Co., Ltd.,, other from Kowa Pharmaceutical Co. Ltd.,, other from Daiichi Sankyo Co., Ltd.,, other from Takeda Pharmaceutical Co., Ltd.,, other from Toa Eiyo Co., Ltd.,, other from Novartis Pharma K.K, other from Bayer Yakuhin, other from Nippon Boehringer Ingelheim Co., Ltd, other from Eli Lilly Japan, other from Sanofi K.K.,, other from Mitsubishi Tanabe Pharma Corporation, other from Astellas Amgen Bio Pharma, other from Pfizer Japan Inc,, other from Bristol-Myers Squibb Company., outside the submitted work;. The other authors have nothing to disclose.